Samuraciclib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Samuraciclib, covering 2025-12-26 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer [Phase 1, Phase 2]